A potent and selective inhibitor of class I histone deacetylases (HDACs). Induces apoptosis in a variety of cell lines and displays antitumor activity in mouse models. Recently approved for clinical use in T-cell lymphoma.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Regulatory Status |
RUO – Research Use Only |
---|